AMBALALSA.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

DCF fair valuemodel estimate

Intrinsic value

$31.21

Price

$39.40

Implied downside

-21%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
AMBALALSA.BOAmbalal Sarabhai Enterprises Limited	$39.36	+1.89%	$3.0B	—
BDH.BOBDH Industries Limited	$500.00	-1.01%	$2.9B	—
CORALAB.BOCoral Laboratories Limited	$570.90	+0.95%	$2.0B	—
NATCAPSUQ.BONatural Capsules Limited	$172.75	-4.72%	$1.8B	—
NURECA.BONureca Limited	$334.50	+2.61%	$3.3B	—
NURECA.NSNureca Limited	$338.30	+5.00%	$3.4B	—
OXYGENTAPH.BOOxygenta Pharmaceutical Ltd.	$52.76	-1.27%	$2.0B	—

Source: Financial Modeling Prep · peers by sector/industry

Ambalal Sarabhai Enterprises Limited

Ambalal Sarabhai Enterprises Ltd. operates as a holding company with investments across the pharmaceutical and electrical industries. Its core activities include the production and marketing of pharmaceutical goods. The company was established on June 27, 1977, and its principal office is located in Ahmedabad, India.

www.ase.life

Employees: 547
IPO / List date: May 4, 2000
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds AMBALALSA.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in AMBALALSA.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded AMBALALSA.BO yet.